AMRX Amneal Pharmaceuticals, Inc.: institutional ownership and insider trading
337 funds reported holding $3.11B of Amneal Pharmaceuticals, Inc. in their latest 13F filings; in Q2 2026 funds net bought $41.8M, with 44 new positions and 52 funds selling out; over the last 12 months insiders bought $0 and sold $9.82M on the open market; over its last four quarters it reported revenue of $3.12B and net income of $157M.
AMRX revenue and earnings
- Quarter ended Jun 30, 2026: revenue $796M, net income $57.7M, EPS 0.18
- Quarter ended Mar 31, 2026: revenue $723M, net income $62.3M, EPS 0.19
- Quarter ended Dec 31, 2025: revenue $814M, net income $35.1M, EPS 0.10
- Quarter ended Sep 30, 2025: revenue $785M, net income $2.37M, EPS 0.01
Famous investors holding AMRX
- D. E. Shaw (D. E. Shaw & Co.): $13.4M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $19.9M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $4.04M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $1.51M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $256K, 0.0% of the portfolio
Largest institutional holders of AMRX
- BlackRock, Inc. (BLK) — $460M
- VANGUARD GROUP INC — $226M
- TPG GP A, LLC — $213M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $210M
- Rubric Capital Management LP — $176M
- VANGUARD CAPITAL MANAGEMENT LLC — $133M
- STATE STREET CORP (STT, STT-PG) — $127M
- DIMENSIONAL FUND ADVISORS LP — $100M
- GEODE CAPITAL MANAGEMENT, LLC — $89.0M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $71.1M
Recent AMRX insider trades
- Aug 13, 2026: Kiely John sold 50,000 shares ($882K)
- Aug 12, 2026: Daly Jason B. sold 216,613 shares ($3.77M)
- Aug 12, 2026: Shah Nikita sold 146,403 shares ($2.56M)
- May 11, 2026: Autor Deborah M. sold 34,819 shares ($451K)
5%+ owners
- Tushar Patel: 17.6% (Schedule 13D/A, filed Aug 12, 2026)
- Chintu Patel: 9.4% (Schedule 13D/A, filed Aug 12, 2026)
- Chirag Patel: 8.4% (Schedule 13D/A, filed Aug 12, 2026)
- BlackRock, Inc.: 7.6% (Schedule 13G, filed Apr 27, 2026)
- Patel Dipan: 5.4% (Schedule 13D/A, filed Mar 26, 2026)